Piracetam for Cognition (healthy young) and Piracetam
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Piracetam for Cognition (healthy young)
Evidence grade D — Weak
Grade D1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Piracetam
The original 'nootropic' — decent evidence in cognitive impairment, thin data in healthy people, and unapproved as a supplement in many places.
Grade C2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Piracetam for Cognition (healthy young) | Piracetam |
|---|---|---|
| Cognition (healthy young) | Evidence grade DTrivial effectlowWeak | Evidence grade DTrivial effectlowWeak |
Graded only in Piracetam for Cognition (healthy young)
None — every outcome it grades is graded in both.
Graded only in Piracetam
- Cognition (impairment/elderly) Small effectEvidence grade C
What each entry says about the other
- Piracetam for Cognition (healthy young)’s entry · Goes with: Read the full Piracetam monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.